Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2

Interventions

pembrolizumab 514Specimen Handling 384Carboplatin 372Magnetic Resonance Spectroscopy 337Cisplatin 327Nivolumab 301Cyclophosphamide 297Radiotherapy 255Paclitaxel 255Biopsy 237Gemcitabine 229Bevacizumab 212Dexamethasone 168durvalumab 162Oxaliplatin 159Capecitabine 154Rituximab 153Fluorouracil 148venetoclax 143atezolizumab 142Drug Therapy 140Docetaxel 140Etoposide 139Doxorubicin 132Ipilimumab 124Lenalidomide 119Radiosurgery 118Prednisone 116Leucovorin 112fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × ursodoxicoltaurine × 1 year × Clear all
NCT07100392 2025-08-17

LEAF-02

Fudan University

Phase 2 Recruiting
141 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07064668 2025-07-15

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

Tongji Hospital

Phase 2 Not yet recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡